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Proteins of unknown function comprise a significant
fraction of sequenced genomes. Defining the roles
of these proteins is vital to understanding cellular
processes. Here, we describe amethod to determine
a protein function based on the identification of its
natural ligand(s) by the crystallographic screening
of the binding of a metabolite library, followed by
a focused search in themetabolic space. Themethod
was applied to two protein families with unknown
function, PF01256 and YjeF_N. The PF01256 pro-
teins, represented by YxkO from Bacillus subtilis
and the C-terminal domain of Tm0922 from Thermo-
toga maritima, were shown to catalyze ADP/ATP-
dependent NAD(P)H-hydrate dehydratation, a previ-
ously describedorphan activity. The YjeF_Nproteins,
represented by mouse apolipoprotein A-I binding
protein and the N-terminal domain of Tm0922, were
found to interact with an adenosine diphosphori-
bose-related substrate and likely serve as ADP-
ribosyltransferases. Crystallographic screening of
metabolites serves as an efficient tool in functional
analyses of uncharacterized proteins.
INTRODUCTION
The molecular function of an uncharacterized protein is com-
monly assigned on the basis of its sequence or structural simi-
larity to proteins of characterized function. Several experimental
and computational methods have been proposed to assign func-
tion in the absence of functionally characterized homologs or to
refine a general function often inferred by a similarity assignment.
However, the functions of proteins encoded by an estimated
30%–40% of bacterial genes, and even higher fractions of the
genomes of archaea and eukaryotes, remain uncharacterized
and await novel functional assignment methods (Galperin and
Koonin, 2004).Structure 20, 1715–1The identification of a natural small molecule ligand (substrate,
effector, etc.) is one starting point for the determination of a pro-
tein’s molecular function. However, comprehensive screening
of all compounds in a metabolome, estimated at 5,000–25,000
per individual species (Nicholson et al., 2007), is a formidable
task. In order to identify natural ligands, we employed a two-
phase approach that took advantage of structural relationships
among metabolites. In phase I, the binding of compounds in
a diverse metabolic library to a target protein was studied to
identify metabolites that were structurally similar to a natural
ligand and possessed its protein-binding determinants. X-ray
diffraction analysis of protein crystals soaked with multicom-
pound cocktails was used, due to its ability to detect low affinity
binding of ligand analogs. In phase II, the binding of metabolites
structurally related to the hits fromphase I was evaluated to iden-
tify those that bound to the protein with high affinity. Isothermal
calorimetry (ITC) and crystallographic analysis were used as
detection methods, because both high and low affinity interac-
tions were expected.
This functional assignment strategy was applied to proteins
from two families of unknown function, YjeF_N and PF01256.
In most prokaryotes, the domains representing these two
families exist as a fusion protein with the YjeF_N-PF01256 archi-
tecture. Fused domains are commonly related in function and
often interact with structurally related ligands (Suhre, 2007). In
order to optimize the odds of detecting a ligand, three proteins
were included in the study: two single domain proteins (one
from each family) and a fusion protein (Figure 1A). The single
domain proteins are mouse apolipoprotein A-I binding protein
(AI-BP) and YxkO from Bacillus subtilis, representing the YjeF_N
and PF01256 families, respectively. The YjeF_N-PF01256 fusion
protein included in the study is Tm0922 from Thermotoga
maritima.
YjeF_N Family
The family of YjeF_N proteins represented a particularly chal-
lenging case for functional assignment and was included in
a top 10 list of highly attractive targets for functional character-
ization (Galperin and Koonin, 2004). Currently, there are 2,411
sequences of the YjeF_N family members from 2,009 bacterial,
archaeal, and eukaryotic species in Pfam (Finn et al., 2010). A725, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1715
Figure 1. Subunit Structures and Putative Active Sites of the
Proteins from the YjeF_N and PF01256 Families
(A) The superposition of Tm0922, a YjeF_N-PF01256 fusion (blue) with AI-BP,
a single YjeF_N domain (cyan), and YxkO, a single PF01256 domain (pink). In
the YjeF_N domain, the invariant D188AI-BP is green and highly conserved
residues (Jha et al., 2008) are purple. The sulfate bound in the AI-BP structure
is yellow/red and glycerol bound in the Tm0922 structure is navy/red. In the
PF01256 domain, the invariant D216YxkO is green and the modeled ATP and
Mg2+ (Zhang et al., 2002) are shown.
(B) Surface of the AI-BP subunit colored as in Figure 1A. The pocket
compartment of the putative YjeF_N active site is marked by the red circle, and
its trench compartment is marked by the yellow oval.
(C) Surface of the YxkO subunit colored as in Figure 1A. The predicted
kinase substrate binding site is marked by the yellow circle. The side chains of
F162AI-BP and H149YxkO that block active sites in the apo-structures are
removed.
Structure
Functional Analysis Using Metabolite Cocktailssingle YjeF_N protein is typically present in bacteria and
archaea, but eukaryotes possess up to three paralogs from the
family. The human genome encodes for three YjeF_N paralogs:
the single domain proteins AI-BP and YjeF_N3, as well as
Edc3, which consists of an N-terminal Lsm domain, a central
FDF domain, and a C-terminal YjeF_N domain (Ling et al.,
2008; Rudolph et al., 2007).
Despite their widespread distribution, no biochemical function
has been assigned to any member of the YjeF_N family, and no
information was available regarding their ligand-binding proper-
ties. They were suggested to be involved in a conserved enzy-
matic process (Anantharaman and Aravind, 2004; Galperin and
Koonin, 2004; Jha et al., 2008).
Edc3 is the only member of the YjeF_N family involved in
a defined cellular process and serves as an activator of mes-
senger RNA (mRNA) decapping. However, its mechanistic role
in decapping has not been established. Edc3 binds to the
multiprotein decapping complex via its Lsm and FDF domains
(Decker et al., 2007; Harigaya et al., 2010; Tritschler et al.,1716 Structure 20, 1715–1725, October 10, 2012 ª2012 Elsevier Ltd2009), while the YjeF_N domain was posited to possess an
unknown enzymatic activity, potentially including dephosphory-
lation, demethylation, phosphoester, or glycosyl bond hydrolysis
(Anantharaman and Aravind, 2004). The only demonstrated
binding interaction for an YjeF_N protein is the binding of AI-
BP to apolipoprotein A-I, but its significance is not understood
(Ritter et al., 2002).
The YjeF_N proteins are apparently not essential for cell
survival. Saccharomyces cerevisiae strains with a deletion of
either YNL200C or Edc3 of the YjeF_N family continued to be
viable (Cherry et al., 2012). The single yjeF gene in E. coli, which
encodes a PF01256-YjeF_N fusion protein, was also character-
ized as nonessential (Gerdes et al., 2003; Kato and Hashimoto,
2007).
Analysis of the genomic context of YjeF_N domains revealed
that they commonly fuse with other domains. Single domain
YjeF_N proteins represent only 14% of the sequences available
in Pfam. The dominant fusion partner of the YjeF_N domain
in prokaryotes, constituting 80% of the Pfam sequences, is
a PF01256 domain, annotated as a carbohydrate kinase (see
below). Eukaryotes contain Edc3 orthologs with a (Lsm)-FDF-
YjeF_N architecture (4% of Pfam sequences), which are likely
to be involved in mRNA processing. In some plants, YjeF_N is
fused to a putative pyridoxamine 50-phosphate oxidase (1% of
Pfam sequences). In bacteria and archaea, yjeF genes belong
to operons that encode enzymes of diverse functions: pyridoxal
phosphate biosynthetic protein PdxJ; phosphopantetheine-
protein transferase; ATP/guanosine triphosphate (GTP) hydro-
lase; and pyruvate-formate lyase 1-activating enzyme. Thus,
in genomes, YjeF_N domains are commonly associated with
a diverse set of enzymes and are likely to serve as enzymes;
however, attempts to assign a metabolic context to this putative
activity were unproductive.
Crystal structures available for several members of the
YjeF_N family provided another hint that YjeF_N proteins are
enzymes and suggested the location of a putative active site.
The YjeF_N domains form a modified Rossmann fold (Chance
et al., 2002; Jha et al., 2008; Ling et al., 2008), which is common
for enzymes involved in metabolic functions (Wolf et al., 1999).
Two invariant (G86AI-BP/G48Tm0922 and D188AI-BP/D147Tm0922)
and 11 highly conserved residues in the YjeF_N family are
clustered within or near the cavity on the protein surface
(Figures 1A and 1B) (Jha et al., 2008). This cavity, observed in
every available YjeF_N structure, is positioned at the typical
location of the active site in Rossmann-fold enzymes. The cavity
is comprised of two compartments, a trench that runs along
the protein surface and a perpendicular pocket (Chance et al.,
2002; Jha et al., 2008). In AI-BP, the trench is about 10 A˚
long with a cross-section of 4 A˚ 3 4 A˚, while the pocket is
10 A˚ deep with an 3 A˚ 3 7 A˚ opening. In the available
apo-structures, the trench compartment binds anions present
in crystallization media (sulfate in Protein Data Bank (PDB):
2O8N (Figures 1A and 1B), phosphate in PDB: 3K5W, or
chloride in PDB: 1JZT), while the pocket contained a glycerol
molecule used as cryoprotectant in PDB: 2AX3. The two-
compartmental cavity is likely to serve as an active site in
YjeF_N enzymes. However, attempts to detect residue patterns
associated with a known activity did not produce any definitive
results.All rights reserved
Table 1. Composition of Metabolite Cocktails and Binding in the Putative Active Sites of the AI-BP, Tm0922, and YxkO Crystals
Cocktail Cocktail Composition YjeF_N Active Sites PF01256 Active Sites
AI-BP N-Tm0922 C-Tm0922 YxkO
apo – sulfatea glycerolb – –
A adenine, adenosine, AMP, ADP, ATP,
cAMP, dAMP, sucrose, L-arabinose
sulfatea glycerolb ADP/ATP ADP/ATP
B guanine, guanosine, 20-deoxyguanosine,
GDP, GTP, dGMP, dGDP, dGTP,
D-sorbitol, D-fructose
sulfatea glycerolb – –
C cytosine, cytidine, CMP, CDP, dCMP,
DL-carnitine, D-trehalose, xylitol
sulfatea glycerolb – –
D uracil, uridine, UMP, UDP, UTP, dUMP,
UDP-glucose, D-mannitol, myo-inositol
sulfatea glycerolb – –
E thymine, thymidine, TMP, TDP, TTP, cTMP,
TDP-glucose, 6-phosphogluconic acid
thymine/thymidine, sulfatea glycerolb – –
F pyridoxal phosphate, pyridoxal,
pyridoxamine, phosphocholine,
phosphoethanolamine, phosphoserine,
phosphoglycerol
no diffraction glycerolb – –
G ascorbic acid, NAD, NADP, FAD, betaine,
20-dIMP, deoxycholic acid, CoQ10,
ergocalciferol, a-tocopherol
no diffraction NAD/NADP NAD NAD
H SAM, SAH, CoA, NAAD, nicotinic acid,
biotin, folic acid, thiamine, D-pantothenic
acid, p-aminobenzoic acid,
p-hydroxybenzoic acid
no diffraction p-aminobenzoic acid,
p-hydroxybenzoic acid
– NAAD
I FMN, riboflavin, uric acid, xanthine, pterin no diffraction glycerolb – –
J D-glucose, D-xylose, L-rhamnose,
N-acetylgalactosamine, N-acetyl
muramic acid
sulfatea glycerolb – –
K D-galactose, D-mannose, L-fucose,
N-acetylglucosamine, N-acetyl
neuraminic acid
sulfatea glycerolb – –
aSulfate, a component of crystallization media for AI-BP, was bound in the trench compartment of the YjeF_N site.
bGlycerol, a cryoprotectant for Tm0922 crystals, was bound in the pocket compartment of the YjeF_N site.
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Functional Analysis Using Metabolite CocktailsPF01256
The PF01256 family contains 2,945 sequences from 2,445
species representing every kingdom of life. A single PF01256
protein is present in most organisms. Gene deletion of
PF01256 does not affect cell viability in either E. coli (Gerdes
et al., 2003; Kato and Hashimoto, 2007) or S. cerevisiae (Cherry
et al., 2012). Sixty-five percent of PF01256 domains described in
Pfam exist as YjeF_N-PF01256 fusions, 33% are present as
single domain PF01256 proteins, and 0.4% form fusions with
a 40-phosphopantetheinyl transferase domain.
The PF01256 proteins were annotated with the general
function of carbohydrate kinase, due to their sequence and
structural similarity to small molecule kinases from the riboki-
nase clan (Zhang et al., 2002). Enzymes from this clan catalyze
the transfer of a phosphate group from ATP or ADP to a hydroxyl
group of various small molecule substrates. Based on high
structural similarity among members of the ribokinase clan,
ATP/Mg2+ binding in PF01256 has been modeled and a catalytic
role was proposed for the invariant aspartate residue (D216YxkO/
D431Tm0922) (Figures 1A and 1C) (Zhang et al., 2002). However,
the second substrate, and therefore the function of PF01256
proteins, remained unknown.Structure 20, 1715–1RESULTS AND DISCUSSION
Phase I: Crystallographic Screening of Metabolite
Cocktails
Proteins have evolved to efficiently interact with their partner
compounds in the cell and to ignore unrelated metabolites
present at physiological concentrations. This natural selection
has not been driven by compounds foreign to the cell, such as
drugs, which may exhibit strong interactions with a protein. We
suggest that 1) the high selectivity of a protein toward its natural
ligand may not preclude low affinity binding of ligand analogs
that bind in the same mode and 2) a search for ligand analogs
in the metabolome decreases the probability of nonspecific
binding in comparison to using nonphysiological compounds.
The crystals of the apo-forms of AI-BP, Tm0922, and YxkO
were soakedwith 11 cocktails comprising 87 commercially avail-
able natural metabolites, each present at 10 mM concentration
(Table 1), and the structures of these crystals were determined.
Each cocktail included 5–11 metabolites. Structurally similar
compounds were usually combined in the same cocktail in order
to increase the efficient concentration of their common frag-
ments and facilitate the detection of binding. The metabolite725, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1717
Figure 2. Representative FO-FC Omit Electron Density Maps of the
Bound Ligands in Metabolite Cocktail Soaks and Soaks with Single
Ligands
(A) NADP is modeled in the NAD/NADP density in the Tm0922 crystal soaked
with the cocktail G (resolution 2.05 A˚, s = 2.5). The disordered or hydrolyzed
nicotinamide ring is not shown.
(B) NADP soaked into the Tm0922 crystal (resolution 1.95 A˚, s = 2.5).
(C) Thymidine is modeled in the thymine/thymidine density in the AI-BP crystal
soaked with the cocktail E (resolution 2.5 A˚, s = 2.0).
(D) Thymidine soaked into the AI-BP crystal (resolution 2.11 A˚, s = 2.5).
Figure 3. The Binding Sites of Metabolitic Ligands in the YjeF_N and
PF01256 Active Sites
In the YjeF_N domain, ADP-ribose (yellow) marks the binding site for the NAD
set of ligands, while thymidine (orange) is bound at the thymine set site. In the
PF01256 domain, bound AMP, Mg2+, and NADPHX are shown in magenta,
black, and green, respectively.
Structure
Functional Analysis Using Metabolite Cocktailslibrary was mostly composed of cofactors and compounds that
contain common metabolic building blocks. Some groups of
common metabolites, such as amino acids and lipids, were
omitted from the initial library in order to be tested in the next
round of screening if the first metabolite selection did not
produce results.
Indications of a ligand binding to a crystal include the presence
of additional electron density in the structure or abolishment
of diffraction, though nonspecific disruption of crystal packing
cannot be ruled out in the latter case. Determination of the struc-
tures of cocktail-soaked crystals revealed new electron density
peaks in all four putative active sites.
YjeF_N Sites
The putative YjeF_N active sites present in AI-BP and the
N-terminal domain of Tm0922 (N-Tm0922) are composed of
a trench and pocket compartments, as described above. In
structures of apo-protein, the trench of the AI-BP active site is
occupied by a sulfate present in the crystallization media, while
the pocket of N-Tm0922 contains a bound glycerol (which serves
as a cryoprotectant).
Upon the exposure to metabolite cocktails, all Tm0922 crys-
tals retained their diffraction power and two acquired new elec-
tron density peaks in their YjeF_N sites. The electron density
acquired by crystals soaked in cocktail G (Table 1) was readily
assigned to nicotinamide adenine dinucleotide phosphate
(NADP), which bound along the trench compartment (Figures
2A, 2B, and 3). This NADP-binding site is likely to be partially
occupied by nicotinamide adenine dinucleotide (NAD), as indi-
cated by the higher B-factors of the 20 phosphate group of the
modeled NADP. The exposure of Tm0922 crystals to cocktail1718 Structure 20, 1715–1725, October 10, 2012 ª2012 Elsevier LtdH gave rise to new electron density in the pocket compartment
of the YjeF_N site. The compounds responsible for this electron
density were not immediately recognized, but subsequent soaks
with individual components demonstrated binding of both
p-aminobenzoate and p-hydroxybenzoate. All other cocktail-
exposed crystals of Tm0922 contained a glycerol molecule
bound in the YjeF_N site, as in the structure of the apo-protein.
Residual electron density was observed in the pocket com-
partment of the putative active site in the AI-BP crystal exposed
to cocktail E (Table 1; Figures 2C and 3). This crystal diffracted to
a relatively low resolution of 2.7 A˚, precluding reliable identifica-
tion of the bound ligand(s). However, subsequent soaking with
individual metabolites from cocktail E identified bound com-
pounds as thymine and thymidine (Figure 2D). AI-BP crystals
soaked with cocktails retained a sulfate bound in the trench
compartment of the YjeF_N site due to the presence of 1.5 M
sulfate in the crystallization media.
In contrast to the Tm0922 crystals, the diffracting power of
cocktail-exposed AI-BP crystals was diminished. Most of them
diffracted to a resolution better than 3.0 A˚, which did not
preclude the detection of bound ligands. However, diffraction
of the crystals soaked with cocktails F, G, H, and I was com-
pletely abolished. Soaks with individual components showed
that the compounds responsible for the loss of diffraction were
pyridoxal phosphate in cocktail F and both flavin mononucleo-
tide (FMN) and riboflavin in cocktail I. It is likely that FMN and
riboflavin affected the crystal packing of AI-BP, because the
properties of the crystals soaked with either compound were
clearly altered. In addition to acquiring a yellow color, the AI-
BP crystals soaked with FMN became gel-like, while crystals
exposed to riboflavin acquired resistance to breaking uncharac-
teristic of the crystals of the apo-protein. Disruptions of the
crystal packing of AI-BP may be related to binding of both
FMN and riboflavin in the pocket compartment of the AI-BP
active site. These compounds differ from each other only by
the presence of a phosphate group, and both contain a substruc-
ture similar to thymine (Figure S2 available online). Thus FMN
and riboflavin may interact with AI-BP in a similar manner. TheAll rights reserved
Figure 4. Binding of the NAD Set Ligands in
the YjeF_N Site of Tm0922
(A) All ligands that contain an ADP moiety are
bound in a similar mode along the trench
compartment. NADP missing the nicotinamide
ring is in a thick stick representation colored by the
atom type. The other ligands (Table S1) are drawn
as thin sticks and colored by the compound. Only
the fragments visible in the electron density are
shown.
(B) The coordinating polar interactions of NADP.
The invariant D147Tm0922 is green.
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Functional Analysis Using Metabolite CocktailsAI-BP crystals soaked with individual components within cock-
tails G and H showed neither abolished diffraction nor ligand
binding. In this case, abolishment of AI-BP crystal diffraction
was likely due to a change in solution composition rather than
the influence of any component.
PF01256 Sites
The diffracting power of YxkO and Tm0922 crystals was not
significantly altered by soaking with metabolite cocktails. The
putative PF01256 active sites present in YxkO and the
C-terminal domain of Tm0922 (C-Tm0922) bound ATP and
ADP in the predicted ATP-binding site of the crystals exposed
to cocktail A. In addition, both YxkO and Tm0922 crystals
soaked with cocktail G contained NAD in the predicted ATP-
binding site. In YxkO crystals soaked in cocktail H, nicotinic
acid adenine dinucleotide (NAAD) is bound in the same position.
The nearly identical coordination of NAD and NAAD in the ATP-
binding sites mimicked the mode of ATP/ADP binding and, in
addition, involved the interaction of the nicotinamide/nicotinate
ribose with Mg2+. In YxkO, the binding of these compounds
caused the ordering of a binding site loop that was disordered
in the apo-structure. No indication of binding to the kinase
substrate site was obtained in cocktail soaks.
Phase II: Elucidation of YjeF_N Ligands and Discovery of
the PF01256 Kinase Substrate Site
A protein is expected to bind its natural ligand(s) with signifi-
cantly higher affinity than other compounds present in the cell.
Following identification of the initial binding hits, studies of struc-
turally related metabolites were undertaken with the assumption
that compounds similar to the natural ligand bind with higher
affinity, while dissimilar compounds bind with lower affinity.
Two sets of metabolites were designed to elucidate a natural
ligand(s) for the YjeF_N sites, based on the binding hits discov-
ered by the cocktail screening in N-Tm0922 and AI-BP. The
‘‘NAD set’’ contained metabolites structurally related to NAD
and NADP that had been identified in the trench compartment
of the N-Tm0922 site, while the ‘‘thymine set’’ consisted of the
compounds related to thymine and thymidine that had been
noted in the pocket compartment of AI-BP. TheNADset included
NAD, NADP, adenine, adenosine, AMP, cyclic AMP (cAMP),
ADP, ADP-ribose (ADPR), NADH, NAAD, nicotinamide adenine
dinucleotidephosphate reduced (NADPH), nicotinic acid adenine
dinucleotide phosphate (NAADP), ADP-glucose (ADPG), ATP,
P1,P3-di(adenosine-50) triphosphate (AP3A), P
1,P4-di(adeno-
sine-50) tetraphosphate (AP4A), P
1,P5-di(adenosine-50) penta-
phosphate (AP5A), P
1,P6-di(adenosine-50) hexaphosphateStructure 20, 1715–1(AP6A), flavin adeninedinucleotide (FAD), CoA, acetyl CoA, aden-
osine 30,50-diphosphate, S-adenosyl methionine (SAM), S-ad-
enosyl homocysteine (SAH), and b-nicotinamide mononucleo-
tide (Figure S1). The thymine set included thymine, thymidine,
thymidine monophosphate (TMP), cyclic TMP (cTMP), thymidine
30-monophosphate (T30MP), thymidine diphosphate (TDP),
TDP-glucose, thymidine triphosphate (TTP), uracil, uridine,
uridinemonophosphate (UMP), 20-deoxyuridinemonophosphate
(dUMP), uridine diphosphate (UDP), UDP-glucose, uridine
triphosphate (UTP), cytosine, cytidine, cytidine monophosphate
(CMP), 20-deoxycytidine monophosphate (dCMP), cytidine
diphosphate (CDP), riboflavin, flavin mononucleotide (FMN),
lumazine, uric acid, xanthine, guanine, and pterin (Figure S2).
Binding of metabolites from both sets to Tm0922 and AI-BP
was characterized both by crystallographic and isothermal titra-
tion calorimetry (ITC) analysis. We did not intend to characterize
interactions of the listed metabolites with a PF01256 domain,
because the ligands observed in the PF01256 domains (the
C-terminal domain of Tm0922 and YxkO) by cocktail screening
occupied only the predicted ATP-binding site and did not
provide any leads in a search for the unknown second substrate.
However, the presence of both domains in Tm0922 provided
these data, leading to the discovery of a PF01256 function.
Binding of NAD-Related Metabolites
N-terminal (YjeF_N) Domain of Tm0922—Crystallography. In
Tm0922 crystals soaked with individual metabolites from the
NAD set, 14 of 15 compounds containing an ADP moiety were
found in the trench of the YjeF_N site (Figures 3 and 4; Table
S1). The remaining ADP-containing ligand, AP6A, may have
also bound to Tm0922, but the crystals soaked with AP6A did
not diffract. The position of the ADP fragment and its coordina-
tion by the residues of the YjeF_N site was nearly identical for
each of the bound compounds (Figure 4). The binding was
accompanied by a conformational change in the active site
loop that created a specific binding site for the ADP fragment.
This conformational change included flips of the T119-G120
and R122-G123 peptide planes that enabled coordination of
the a-phosphate and adenine groups of the ligands, respec-
tively. The coordination of NADP/NADPH/NAADP or CoA/acetyl
CoA also involved the interaction between K78 and their 20 or 30
phosphate groups, respectively. The non-ADP tails of the bound
ligands directed toward the pocket compartment of the YjeF_N
site were partially disordered in most complexes (Figure 4A).
However, when the ligand contained a ribose attached to the
b-phosphate of the ADP fragment (as in ADPR, NAD, NADH,
NAAD, NADP, NADPH, andNAADP), this ribose waswell defined725, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1719
Figure 5. Binding of the NAD Set Metabo-
lites in the PF01256 Active Sites and the
Reaction Catalyzed by PF01256 Proteins
(A) Ligands in the NAD(P)H soaks of Tm0922 bind
in its kinase substrate site differently from the other
ligands. NADPHX is in a thick stick representation
colored by the atom type. The other ligands (Table
S1) are drawn as thin sticks and colored by the
compound. Ligands bound at the ATP-binding site
in the upper half are not shown, except for ATP and
Mg2+ from the ATP soak. Only the fragments
visible in the electron density are shown. The
second subunit of Tm0922 contributing to the
PF01256 active site is not shown for clarity.
(B) Coordination of NADPHX in the active site of
YxkO, cocrystallized with ATP and Mg2+, and
soaked with NADPH. The FO-FC omit electron den-
sity map calculated to 1.5 A˚ resolution and con-
toured at 4.0s demonstrates themodification of the
nicotinamide ring of NADPH and hydrolysis of ATP
to AMP. Residues from two YxkO subunits forming
the active site are colored in pink and yellow.
(C) The reaction catalyzed by the orphan enzyme
ATP-dependent NAD(P)H-hydrate dehydratase
(EC 4.2.1.93) and spontaneous hydratation of
NAD(P)H. R is a hydroxyl group in NADH/NADHX
and a phosphate group in NADPH/NADPHX.
Structure
Functional Analysis Using Metabolite Cocktailsin the electron density and coordinated by several active site
residues, including the invariant D147 (Figure 4B). In contrast,
the nicotinamide rings of the NAD(P) analogs were not visible
in the electron density.
AI-BP—Crystallography. The trench compartment of the
YjeF_N site in AI-BP crystals bound NADP (Figure 3; Table S2).
ADPR, NADH, and NADPH might also have bound, but the
diffraction of AI-BP crystals soakedwith these compounds dete-
riorated below 5 A˚, impeding the reliable modeling of ligands.
The coordination of NADP in the YjeF_N site of AI-BP was similar
to that in the N-Tm0922 site. Flips in two peptide planes enabled
binding of the ADP fragment. As in the Tm0922 complex, the
nicotinamide ribose of NADP was well-defined in the electron
density due to extensive coordination, but the nicotinamide
ring was not visible. The apparent higher selectivity of the YjeF_N
site in AI-BP as compared to N-Tm0922 is likely to be related to
the presence of sulfate in the AI-BP, but not Tm0922 crystalliza-
tion media. This sulfate replaced ligands with lower affinities in
the trench compartment of AI-BP.
C-terminal (PF01256) Domain of Tm0922—Crystallography.
Interactions of test ligands with the PF01256 site of Tm0922
complexes were also assessed. The ATP binding site accommo-
dated ligands that mimicked the binding of ATP/Mg2+, as was
observed in the cocktail screening. In addition, several NAD
set metabolites bound in the vicinity of the ATP-binding site at
the interface of two C-Tm0922 domains. This second site was
designated a kinase substrate-binding site (Figures 3 and 5).
In contrast to the robust binding of NAD set ligands to the
YjeF_N site, their ability to bind in the adjoining ATP- and kinase
substrate-binding sites of PF01256 varied. ATP and AP3A occu-
pied only the ATP-binding site. NADH, NADPH, CoA, and acetyl
CoA were coordinated only at the kinase substrate site. AMP,
ADP, ADPR, ADPG, NAD, and NAAD bound to both sites, while
NADP, NAADP, AP4A, and AP5A bound to neither site. When the1720 Structure 20, 1715–1725, October 10, 2012 ª2012 Elsevier Ltdcompounds that were able to occupy the kinase substrate site
were soaked into Tm0922 crystals simultaneously with ATP/
Mg2+, they bound at the same position, while ATP/Mg2+ occu-
pied its own binding site (Figure 5A). The coordination of the
ligands at the substrate site involved multiple polar interactions
with residues from two Tm0922 subunits. The non-ADP moieties
of most compounds were directed away from the ATP location
and partially disordered (Figure 5A). The only exceptions were
the NADH and NADPH soaks, where the nicotinamide rings of
both ligands approached the position of the g-phosphate of
ATP, while their ADP moieties were shifted by about 4 A˚
compared to the other bound metabolites. This shift was caused
by multiple interactions between the active site residues and
both the nicotinamide ring and adjoining ribose in the NAD(P)H
soaks (Figure 5B).
CoA was the only ligand that bound to the PF01256 domain
outside its active site. Two molecules of CoA with disordered
pantothenate tails were coordinated on opposite sides of
the active site. These molecules formed fewer interactions with
the Tm0922 residues than CoA bound at the kinase substrate
site. The significance of their interaction with Tm0922 is not
understood.
Tm0922 and AI-BP—ITC. ITC detected the interaction of
Tm0922 and AI-BP with six closely related compounds from
the NAD set (Table 2; Figure 6). Tm0922 demonstrated signifi-
cantly stronger binding than AI-BP to these compounds, but
the relative order of affinities was similar for both proteins:
ADP-ribose > NADP NADPH >> NAADP >> NAD NADH.
The compoundswith highest affinity, ADPR, NADP, and NADPH,
bound to both proteins with a 1:2 stoichiometry—only one mole-
cule of the ligand bound per two protein monomers.
The affinities of the ligand binding observed by ITC correlated
with the coordination patterns observed in the YjeF_N site of
Tm0922, but not in its PF01256 site. In the ITC tests, bothAll rights reserved
Table 2. Isothermal Titration Calorimetry of AI-BP, Tm0922,
and YxkO
Protein/
Ligand Kd (mM) N DH (cal/mol)
DS
(cal/mol/)
AI-BP
ADPR 450.5 ± 30.8 0.60 ± 0.18 21730 ± 6949 57.6
NADP,
NADPH
Weak bindinga
Tm0922
ADPR 5.1 ± 0.4 0.45 ± 0.01 16060 ± 212 29.60
NADPH 5.3 ± 1.2 0.46 ± 0.01 9714 ± 458 8.44
NADP 6.0 ± 0.9 0.46 ± 0.01 9737 ± 355 8.76
NAADP 104.8 ± 11.1 0.980 ± 0.05 5151 ± 424 0.93
NAD,
NADH
Weak bindinga
YxkO
NADH 9.6 ± 0.7 1.11 ± 0.02 24730 ± 482 59.9
NADPH Weak bindinga
ATP 595.2 ± 133.9 1.00 ± 0.05 7944 ± 1294 11.9
aThe binding of NADP(H) to AI-BP, NAD(H) to Tm0922, and NADPH to
YxkO was too weak to reliably determine its parameters at achievable
protein concentrations.
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Functional Analysis Using Metabolite CocktailsNADP and NADPH bound to Tm0922 with similar affinities that
significantly exceed those of NAD and NADH. In the crystal
structures, the YjeF_N site coordinated all four compounds
through the same set of interactions, with binding of NADP and
NADPH being reinforced by the interaction of their 20-phosphate
with K78. In contrast, the residues of the PF01256 site formed
numerous polar interactions with the nicotinamide and nicotin-
amide ribose moieties of both NADPH and NADH, but not
NAD, and NADP did not bind at all (Figure 5A). In addition, the
1:2 molar ratio between high affinity ligands and Tm0922 corre-
sponded to the stoichiometry observed with AI-BP, which
contains only one YjeF_N site. Therefore, it is likely that ITC de-
tected the interaction of the NAD set ligands only with the YjeF_N
site of Tm0922.
Comparison of structural and ITC binding data for Tm0922
highlighted differences in the detection of protein-ligand
binding in crystals versus solution. Due to the sensitivity of the
method, ITC was able to detect interactions of the YjeF_N
sites of both Tm0922 and AI-BP only with high affinity ligands.
The affinity of the other ADP-containing ligands to YjeF_N sites
was too low to be detected by ITC. The ability of the PF01256
site of Tm0922 to tightly bind its ligands appears to be com-
promised, as no interaction with this site was detected by
ITC for any NAD set ligand, including expected substrates
ATP and ADP. On the other hand, crystallographic analysis led
to detection of both low and high affinity binding in the YjeF_N
sites of AI-BP and N-Tm0922 as well as in the PF01256 site
of C-Tm0922. Notably, ITC provided qualitative affinity and
stoichiometric characterization of the high affinity binding
not achievable by crystallographic analysis. Thus, the com-
bination of the two methods provided a powerful tool for the
characterization of the interactions between proteins and their
ligands.Structure 20, 1715–1Binding of Thymine-Related Metabolites
T30MP was the only thymine set compound besides thymine
and thymidine that bound in the AI-BP active site in crystals
(Table S2). The position and orientation of T30MP in the pocket
compartment of the YjeF_N site of AI-BP was similar to those
of thymine and thymidine (Figure 7A–7C). No binding of thymine
set ligands in the YjeF_N site of Tm0922 crystals was detected.
ITC did not detect binding of any compound from the thymine
set to either AI-BP or Tm0922. The failure to detect binding of
thymine and thymidine to AI-BP observed in the crystals can
be related to a low affinity (Kd >10 mM) or to a low enthalpy
component of binding that was not detected by ITC at the tested
protein concentrations.
Identification of the PF01256 Substrate and Function
Although the putative kinase substrate binding site in Tm0922
accommodated various ligands in crystal soaks, interactions
with these ligands were not detected in solution by ITC. The
reasons for the inhibition of the binding in the PF01256 site of
Tm0922 are not clear from the crystal structures, but a likely
reason is an allosteric regulation of ligand binding among two
domains present in Tm0922. We studied the interaction of
the NAD set metabolites with YxkO, which contains a single
PF01256 domain and thus should not exhibit cross-domain allo-
steric regulation.
ITC detected the tight binding of YxkO to NADH, but not to
other tested compounds (Table 2). When the crystals of the
apo-form of YxkO were soaked with individual metabolites,
several compounds bound at the active site (Table S3). However,
in contrast to Tm0922, all bound ligands mimicked ATP binding,
leaving the kinase substrate site vacant. The loop Asp19-Gly25,
which is disordered in the apo-form of YxkO, became ordered
upon ligand binding at the ATP site.
When YxkO*ATP*Mg2+ crystals obtained by cocrystallization
were soaked with either NADH or NADPH (Table S4), a well-
defined ligand was observed in the kinase substrate site, while
the ATP binding site was occupied by AMP/Mg2+ (Figure 5B).
The ligand coordination was similar to that observed in the
NAD(P)H soaks of Tm0922. The Asp19-Gly25 loop was involved
in coordination of both NAD(P)H and AMP. A modification of the
nicotinamide ring of NAD(P)H due to the saturation of the double
bond between its C5 and C6 atoms was clearly visible at 1.5 A˚
resolution (Figure 5B). The same modification was present in
the Tm0922 soaks, but was not initially identified, due to lower
resolution.
NAD(P)H is known to undergo a spontaneous nonphysiologi-
cal 5,6-hydratation, converting it to NAD(P)H-hydrate (NAD(P)
HX) (Johnson and Tuazon, 1977). In the cell, NAD(P)HX is
converted back to NAD(P)H in an ADP/ATP-dependent reaction
(Figure 5C). The enzyme catalyzing this dehydratation, EC
4.2.1.93, has been characterized biochemically, but was not
associated with a gene (Acheson et al., 1988; Meinhart et al.,
1956). The ligands bound in the kinase substrate sites of both
YxkO and Tm0922 crystals soaked with NAD(P)H were success-
fully modeled as NAD(P)HX (Figure 5B), suggesting that the
PF01256 proteins are responsible for this orphan ‘‘metabolite
repair’’ activity. Kinetic studies revealed that YxkO efficiently
catalyzes dehydratation of both NADHX and NADPHX in the
presence of ADP or ATP. In the reaction between NADHX and725, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1721
Figure 6. Isothermal titration calorimetry
profiles and fitting curves
The binding of ADP-ribose to Tm0922 (A) and
AI-BP (B).
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NADHX, Km
ADP, and kcat values were 0.30 ± 0.04 mM,
6.43 ± 0.49 mM, and 0.35 ± 0.01 s1, respectively. Thus, YxkO
is an ADP/ATP-dependent NAD(P)H-hydrate dehydratase (EC
4.2.1.93), a function likely shared by other members of the
PF01256 family. After the results of this work, including the
assignment of the PF01256 function to EC 4.2.1.93, were depos-
ited in the PDB, the same function of the PF01256 proteins was
independently reported (Marbaix et al., 2011) by purifying the
previously described enzymatic activity from yeast (Acheson
et al., 1988; Meinhart et al., 1956) and identifying the protein by
mass spectrometry.
Closing in on a YjeF_N Function
The results of our studies indicate that the putative active sites of
YjeF_N proteins are designed to bind ADP-ribose/ADP-ribose
phosphate (ADPR(P))-containing ligands. The Kyoto Encyclo-
pedia of Genes and Genomes database (Kanehisa and Goto,
2000) contains only 16 metabolites that include an ADPR(P)
moiety, 15 of which are either substrates or products of
NAD(P)-dependent reactions. Thus, the function of YjeF_N pro-
teins is likely to involve an NAD(P)-related metabolite.
TheYjeF_N site contains an invariant aspartate (Asp147Tm0922/
Asp188AI-BP) that interacts with the nicotinamide ribose of bound
NAD(P). Among NAD(P)-dependent enzymes, a similar acidic
residue is present in poly(ADP-ribose) polymerases (PARPs),
mono-(ADP-ribosyl) transferases (ARTs) and some dehydroge-
nases (Lin, 2007; Schubert et al., 2002).
The reactions catalyzed by PARPs and ARTs deplete an
NAD(P)(H) pool in the cell by transferring the ADPR moiety to
various acceptors, while the reactions that involve dehydroge-
nases do not alter the total NAD(P)(H) concentration. The YjeF_N
domain is found in fusions with enzymatic domains linked to the
replenishing of the NAD(P)(H) pool, PF01256, and pyridoxal
50-phosphate (PLP) synthase. The latter fusion is found in plants,
where the major pathway of NAD(P) biosynthesis includes the
PLP-dependent conversion of nicotinate to nicotinamide (Noctor
et al., 2006).1722 Structure 20, 1715–1725, October 10, 2012 ª2012 Elsevier Ltd All rights reservedBoth thymine and thymidine, which
bind in the active site of mouse AI-BP,
but not bacterial Tm0922, are known
inhibitors of PARP activity, which is
mainly present in eukaryotes (Lin, 2007).
When AI-BP and Tm0922 crystals were
soaked with other known PARP inhibi-
tors, theophylline and nicotinamide (Skid-
more et al., 1979), binding was observed
only in the active site of AI-BP (Figure 7
D and 7E; Table S2). The chemically
diverse PARP inhibitors are unlikely to
serve as substrates of a common enzy-
matic reaction catalyzed by AI-BP, but
rather demonstrate a similar inhibitionpattern of AI-BP and PARP. Indeed, the binding of any of these
potential inhibitors in the pocket compartment would prevent
binding of NAD(P)-related compounds, due to a steric hindrance
with the nicotinamide ring (Figure 7F). In addition, the invariant
aspartate is involved in the coordination of thymine-related
ligands.
Thus several lines of evidence suggest that the YjeF_N
proteins are involved in the reactions involving an ADPR(P) trans-
fer, although they do not possess a significant similarity to the
known PARPs and ARTs in both sequence and structure. We
were unable to detect incorporation of labeled NAD(P)(H) into
proteins in the presence of AI-BP or Tm0922. However, most
ADP-ribosylation reactions are tightly regulated, and the activa-
tion of AI-BP and Tm0922 may require an additional factor or
involve a nonprotein target molecule.
Metabolite Cocktail Screening as a Tool for
Determination of Unknown Protein Function
Proteins are extremely selective binders, yet they are not abso-
lutely selective. The present work demonstrates that this ‘‘imper-
fection’’ can be successfully exploited in functional analyses.
The described approach to functional assignment is reminiscent
of fragment-based drug discovery. It includes an initial identifica-
tion of binding hits with X-ray crystallography followed by the
optimization of binding. However, an important constraint that
simplifies the search for a natural binding partner is that the
compound of interest belongs to a relatively limited metabolic
space. The relatively small 87 compound library used in the study
provided amuch better coverage of themetabolic space (5,000–
25,000 compounds per individual species; Nicholson et al.,
2007) than the largest available chemical compound collections
used for high-throughput screening (106 compounds) provide
for a drug-like chemical space, which is estimated to contain
on the order of 1060 compounds (Carr and Jhoti, 2002). However,
increasing the size and diversity of the metabolic library would
significantly benefit the study. The efficiency of the metabolic
libraries can be further improved by incorporating any functional
Figure 7. Coordination of Putative Inhibitors
in the YjeF_N Site of AI-BP
(A–E) Thymine (A), thymidine (B), thymidine
30-monophosphate (C), nicotinamide (D), and
theophylline (E) are colored by the atom type.
(F) Binding of these ligands (colored by the
compound) in the AI-BP active site would interfere
with the binding of the NAD-related substrate, due
to the steric hindrance with a nicotinamide ring.
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Functional Analysis Using Metabolite Cocktailsinformation available from experimental data or predictions.
Once the initial binding hits are identified, an expanded set of
ligands, still restricted to the metabolic space, is used to identify
a natural binding partner that is expected to bind with a higher
affinity. The number of metabolites in the NAD set (25 com-
pounds) and the thymine set (27 compounds) designed after
detection of NAD/NADP and thymine/thymidine binding is
appropriate for a quantitative binding study.
X-ray crystallography is an effective technique for character-
izing the low affinity binding of proteins to small molecule ligands
(Carr and Jhoti, 2002). The major advantage offered by protein
crystallography in detecting low affinity protein-ligand interac-
tions is related to using high ligand concentrations as well
as dramatically greater protein concentrations than in other
methods. High ligand concentrations can be used for soaking
without a risk of producing false positive hits, due to, for example,
interfering with high throughput screening (HTS) assays. The
concentration of ligands used in the crystallographic experiment
is limited only by the stability of protein crystals. In the
present study, ligand concentrations used in the crystal soaking
reached 50 mM. In addition, the concentrations of AI-BP
(29.5 kDa, 59% solvent), Tm0922 (54.5 kDa, 52% solvent), and
YxkO (30.1 kDa, 58% solvent) in the crystals were 20.0 mM,
9.5 mM, and 19.2 mM, respectively. The protein concentrations
employed in the other methods used to detect binding of
a protein to a small molecule range from picomolar (or less) to
micromolar when enzymatic assays are used in HTS and from
micromolar to low millimolar in nuclear magnetic resonance.
The binding of a ligand to a protein in crystals appears to be
comparable to their binding in solution unless specific complica-
tions arise, such as blockade of the binding site due to the crystal
packing or restriction of domain movement required for the
formation of the binding site. The significant increase in both
ligand and protein concentrations compared to the other
methods of binding detection leads to the proportional increase
in the detection limit and enables characterization of the low
affinity binding.Structure 20, 1715–1725, October 10, 2012 ªAn important consideration recom-
mending a crystallographic approach to
functional analysis is the resources avail-
able from structural genomics, which
have determined the structures of 1,912
proteins of unknown function, including
Tm0922 and YxkO described here. In
addition to the benefits provided by the
structures themselves, follow-up studies
of these proteins can make use of the
publically available genetic constructsand crystallization protocols, overcoming a long-recognized
bottleneck, the preparation of the well-diffracting crystals.
Crystallographic detection of binding requires that the ligand
be able to diffuse into the active site. This restricts the list of
acceptable ligands to small molecules. However, information
useful to functional analyses of protein-macromolecule com-
plexes might be obtained by investigating a pool of small binding
determinants, e.g., peptides or oligonucleotides, or by identifying
a small molecule effector. Another condition for successful crys-
tallographic detection is that ligand binding should not be
impeded by the crystal contacts. The structure of the apo-protein
should be analyzed to ensure that the putative binding site is not
shieldeddue to thecrystal packing. Fortunately, theactive sites in
crystal structures tend to show some degree of disorder in the
absence of bound ligands, indicating that they are not signifi-
cantly constrained. This work shows that small scale conforma-
tional changes in a protein, such as a change in a loop conforma-
tion required for the substrate tobind, canbe tolerated in crystals.
However, ligand binding that requires a large scale change, such
as domain movement, is less likely to be detected.
Crystallographic screening of metabolite library binding can
become a powerful new tool for functional analysis of unknown
proteins, useful particularly when little or no functional informa-
tion is available. A significant advantage offered by the crystallo-
graphic approach is that, in addition to identifying natural
ligands, successful studies also provide exhaustive structural
characterization of the interactions between the protein and
substrates, effectors, or their analogs.
EXPERIMENTAL PROCEDURES
Protein Purification and Crystallization
Selenomethionine-substituted mature AI-BP was expressed, purified, and
crystallized as described previously (Jha et al., 2008). The clones encoding
YxkO and Tm0922 were obtained from the MCSG and JCSG; the proteins
were expressed and purified as described previously (Donnelly et al., 2006;
Lesley et al., 2002) and crystallized according to the protocols described in
the PDB depositions 1KYH and 2AX3. The crystals of YxkO*ATP*Mg2+ were2012 Elsevier Ltd All rights reserved 1723
Structure
Functional Analysis Using Metabolite Cocktailsgrown at 20C using the hanging dropmethod, where the drop contained a 1:1
mixture of a solution containing 25 mg/ml protein and 10 mM ATP with the
crystallization buffer composed of 13.5% (v/v) polyethylene glycol (PEG)
400, 0.09 M MgCl2, 5% glycerol, and 0.045 M 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES) pH 7.5.
Preparation of Crystal Soaks and Structure Determination
Before soaking, the crystals of YxkO were stabilized by equilibration against
the mother liquor, containing 35% PEG 400, while the Tm0922 and AI-BP
crystals were derivatized without additional treatment. The metabolite
cocktails (Table 1) were prepared as aqueous solutions or suspensions at
100 mM concentration of each component. To minimize crystal damage,
0.2 ml of each cocktail was mixed with 0.8 ml of the mother liquor and then
combined with a 1 ml crystallization drop and incubated for 4–10 days.
X-ray diffraction data were collected from the crystals flash cooled with liquid
N2 and maintained at 100 K at the 19-ID, 19-BM, 21-ID-F, and 21-ID-D beam-
lines at Argonne National Laboratory. HKL-3000 (Minor et al., 2006) was used
for the crystallographic data collection and processing, structure solution, and
refinement. The structures of AI-BP, Tm0922, and YxkO complexes were
solved by molecular replacement using the corresponding apo-structures
(PDB: 2O8N, 2AX3, and 1KYH) as models. Depending on the crystal symmetry
group and number of subunits per asymmetric unit (I422/one subunit for
Tm0922 and YxkO; R32/one subunit or C2/six subunits for AI-BP), the time
required to complete initial refinement sufficient to detect the presence of
a bound ligand ranged from less than 20 to 45 min after mounting the crystal
on the goniostat.
Based upon initial binding hits detected in cocktail soaks, two sets ofmetab-
olites, the NAD set and the thymine set, were selected for further study (see
Results and Discussion; Figures S1 and S2). The soaks with individual ligands
were prepared similarly to the cocktail soaks using 50–500 mM stock aqueous
solutions or suspensions.
The 20 structures of Tm0922 complexes were determined at the resolution
1.95–2.6 A˚, with R/Rfree in the range of 15.7–17.4/19.2%–23.7% (Table S1).
The six structures of AI-BP complexes were determined at a resolution of
2.05–2.8 A˚ with R/Rfree in the range of 16.5–20.8/20.1%–24.3% (Table S2).
The 11 structures of YxkO complexes determined at the resolution of 1.5–
1.9 A˚ had R/Rfree in the range of 13.4–16.6/14.8%–19.0% (Tables S3 and
S4). All structures had good stereochemistry. Atomic coordinates and struc-
ture factors for the reported crystal structures have been deposited with the
Protein Data Bank under accession codes reported in Tables S1, S2, S3,
and S4.
Isothermal Calorimetry
Isothermal titration binding assays were carried out at 25C (the binding to
Tm0922 was also tested at 55C) using an iTC200 instrument (MicroCal). The
measurements were carried out in 100 mM HEPES buffer pH 7.5 with
100 mM NaCl using 70–130 mM protein solutions. The final concentrations of
the NAD set and thymine set ligands exceeded the protein concentration
1.2–5 times. Data analysis was conducted with the Origin software (OriginLab).
NAD(P)H-Hydrate Dehydratase Activity of YxkO
NADHX was prepared using the conversion of NADH by glyceraldehyde-3-
phosphate dehydrogenase (Sigma-Aldrich), as described (Miksic and Brown,
1978). NADPHX was prepared by incubating 100 mMNADPH in 0.2 M sodium
phosphate buffer pH 5.0 and adjusting pH to 8.5 after A340 decreased by 75%.
The enzymatic activity of YxkO was assayed as described (Acheson et al.,
1988) by monitoring conversion of NAD(P)HX to NAD(P)H at 340 nm (Dε340 =
6200 M1cm1) at 25C. Kinetic parameters for the Michaelis-Menten model
were determined by nonlinear curve fitting using Origin software.
Testing ADPR Transferase Activities of AI-BP and Tm0922
[32P]NADwas purchased from PerkinElmer. [32P]NADPwas produced by ATP-
dependent phosphorylation of [32P]NAD catalyzed by chicken liver NAD kinase
(Sigma-Aldrich). [32P]NADPH was synthesized by reduction of [32P]NADP
by 6-phospho-D-gluconate in the presence of yeast 6-phosphogluconate
dehydrogenase (Sigma-Aldrich). [32P]NADH was obtained by reduction of
[32P]NAD by formate catalyzed by formate dehydrogenase fromPseudomonas
sp. 101 (generous gift from Dr. V.I.Tishkov).1724 Structure 20, 1715–1725, October 10, 2012 ª2012 Elsevier LtdEach of the 32P-labeled metabolites was added to mouse sperm lysate
along with AI-BP and incubated for 30 min at 30C. A similar experiment
with Tm0922 and T.maritima lysatewas performed at 55C. The control exper-
iments were done with human PARP (Sigma-Aldrich) and both lysates at 30C.
The samples were subjected to SDS-PAGE, dried, and positions of the
proteins labeled by [32P]ADPR were determined using phosphoimager.
ACCESSION NUMBERS
The PDB accession numbers for the structures of tm0922 complexes with
AMP*Mg2+, ADP*Mg2+, ATP*Mg2+, NADH*Mg2+, NAD*Mg2+, NADPH*Mg2+,
NADP*Mg2+, ADPR*Mg2+, ADPG*Mg2+, CoA*Mg2+, AcCoA*Mg2+, A-30,50-
DP*Mg2+, AP3A*Mg
2+, AP4A*Mg
2+, AP5A*Mg
2+, NADH*ADP*Mg2+,
NAD*ATP*Mg2+, NADPH*ATP*Mg2+, NADP*ATP*Mg2+, and CoA*ATP*Mg2+
reported in this paper are 3RRB, 3RRE, 3RRF, 3RSQ, 3RSG, 3RU2, 3RSS,
3RS8, 3RT7, 3RT9, 3RTA, 3RTB, 3RS9, 3RSF, 3RRJ, 3RTD, 3RTC, 3RU3,
3RTE, and 3RTG, respectively. The PDB accession numbers for the structures
of AI-BP complexes with NADP, thymine, thymidine, thymidine-30-monophos-
phate, theophylline, and nicotinamide reported in this paper are 3RNO, 3RO7,
3ROE, 3ROG, 3ROX, and 3ROZ, respectively. The PDB accession numbers for
the structures of YxkO complexes with ADPR*Mg2+, AP3A*Mg
2+, AP4A*Mg
2+,
AP5A*Mg
2+, AP6A*Mg
2+, ATP*Mg2+, NADH*ATP*Mg2+, NADPH*ATP*Mg2+,
and CoA*ATP*Mg2+ reported in this paper are 3RQ6, 3RQQ, 3RQX, 3RQ8,
3RQH, 3RPH, 3RQ2, 3RPZ, and 3RQ5, respectively. These structures are
described in Tables S1, S2, S3, and S4.
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